<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00945594</url>
  </required_header>
  <id_info>
    <org_study_id>Cystoscopy</org_study_id>
    <nct_id>NCT00945594</nct_id>
  </id_info>
  <brief_title>Trial Comparing Outpatient Flexible to Rigid Cystoscopy in Females</brief_title>
  <official_title>Randomized Trial Comparing Outpatient Flexible to Rigid Cystoscopy in Females</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oklahoma</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Oklahoma</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this study to assess patient pain scores comparing rigid to flexible
      cystoscopy in females; to assess post procedural complications, including frequency, urgency,
      infection and time to resolution of these symptoms between the two procedures; to assess
      physician perception of patient pain or discomfort with flexible or rigid cystoscopy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a prospective randomized trial study in order to determine to compare rigid and
      flexible cystoscopy in female patients. Patients will be recruited from OU Physicians Pelvic
      and Bladder Health clinic. Patients receive an information leaflet describing the procedure
      prior to their appointment. All procedures are performed by the attending physician.
      Procedures performed by residents and/or fellows are excluded from this study. The vulva is
      cleaned with antiseptic solution and 10 ml of Xylocaine 2% is be instilled into the urethra
      before the endoscope was introduced. A 16 F flexible cysto urethroscope (Storz, Culver city,
      CA) is used for flexible cystoscopy. When rigid cystoscopy is performed, a 17F, 70° scope
      (Storz, Culver city, CA) is used to enable optimal visualization of the lateral bladder wall
      in those with previous continence surgeries. The investigator may choose to use a 30° scope
      when appropriate. Cystoscopy is commenced by recording a postvoid residual ensuring
      appropriate bladder emptying prior to filling. Filling is performed with continuous saline
      infusion until the maximum tolerated capacity or 300 ml. (whichever was reached first). A
      standard systematic approach was adopted to ensure global assessment of the vesical surface.
      This included the bladder dome, the bladder neck, bladder trigone, sidewalls and ureteral
      orifices. The urethroscopy portion of the procedure is performed last. When performing rigid
      cystoscopy, a 0° degree lens is used for this portion of the procedure.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">November 2011</completion_date>
  <primary_completion_date type="Actual">November 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post Procedural Complications, Including Frequency, Urgency, Infection and Time to Resolution of These Symptoms Between the Two Procedures.</measure>
    <time_frame>1 week after procedure</time_frame>
    <description>Post procedural complications, including frequency, urgency, infection and time to resolution of these symptoms between the two procedures. Patients were asked to report frequency or urgency as a &quot;yes&quot; or &quot;no&quot;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of Post-procedure Complications</measure>
    <time_frame>1 week after procedure</time_frame>
    <description>Duration of post-procedure complications, surveyed 1 week post procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Pain Scale</measure>
    <time_frame>Immediately after procedure</time_frame>
    <description>The Visual analog pain scale measures patient-reported pain levels from 0-10, with 0 being no pain reported and 10 being the highest level of pain reported. In this study, researchers compared pain levels between females who had rigid and flexible cystoscopies.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Flexible cystoscopy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>16F flexible cysto urethroscope (Storz, Culver city, CA)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rigid cystoscopy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>17F, 70° scope (Storz, Culver city, CA)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cystoscopy</intervention_name>
    <description>A 16 F flexible cysto urethroscope (Storz, Culver city, CA) is used for flexible cystoscopy. When rigid cystoscopy is performed, a 17F, 70° scope (Storz, Culver city, CA)</description>
    <arm_group_label>Flexible cystoscopy</arm_group_label>
    <arm_group_label>Rigid cystoscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with the following indications for outpatient cystourethroscopy:

               1. Microscopic hematuria or

               2. Voiding dysfunction, or recurrence of urinary incontinence, or

               3. History of recurrent bacterial cystitis

          -  Age &gt;18

          -  Patient willingness to enroll

          -  Patient able to read and understand an English language self- administered
             questionnaire.

        Exclusion Criteria:

          -  Severe detrussor overactivity

          -  Interstitial cystitis or chronic urethral or bladder pain

          -  Acute urinary tract infection

          -  Urinary retention defined as a post void residual &gt;120cc

          -  Pregnancy or planning pregnancy within the next 3 months

          -  Prior urethral surgery

          -  Dementia or inability to complete questionnaires
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lieschen H Quiroz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oklahoma</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Oklahoma Health Sciences Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>July 22, 2009</study_first_submitted>
  <study_first_submitted_qc>July 23, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 24, 2009</study_first_posted>
  <results_first_submitted>May 20, 2014</results_first_submitted>
  <results_first_submitted_qc>June 5, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">June 6, 2019</results_first_posted>
  <last_update_submitted>June 5, 2019</last_update_submitted>
  <last_update_submitted_qc>June 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>flexible cystoscopy</keyword>
  <keyword>rigid cystoscopy</keyword>
  <keyword>bladder</keyword>
  <keyword>outcome assessment</keyword>
  <keyword>pain measurement</keyword>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Flexible Cystoscopy</title>
          <description>16F flexible cysto urethroscope (Storz, Culver city, CA)
Cystoscopy: A 16 F flexible cysto urethroscope (Storz, Culver city, CA) is used for flexible cystoscopy. When rigid cystoscopy is performed, a 17F, 70° scope (Storz, Culver city, CA)</description>
        </group>
        <group group_id="P2">
          <title>Rigid Cystoscopy</title>
          <description>17F, 70° scope (Storz, Culver city, CA)
Cystoscopy: A 16 F flexible cysto urethroscope (Storz, Culver city, CA) is used for flexible cystoscopy. When rigid cystoscopy is performed, a 17F, 70° scope (Storz, Culver city, CA)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Flexible Cystoscopy</title>
          <description>16F flexible cysto urethroscope (Storz, Culver city, CA)
Cystoscopy: A 16 F flexible cysto urethroscope (Storz, Culver city, CA) is used for flexible cystoscopy. When rigid cystoscopy is performed, a 17F, 70° scope (Storz, Culver city, CA)</description>
        </group>
        <group group_id="B2">
          <title>Rigid Cystoscopy</title>
          <description>17F, 70° scope (Storz, Culver city, CA)
Cystoscopy: A 16 F flexible cysto urethroscope (Storz, Culver city, CA) is used for flexible cystoscopy. When rigid cystoscopy is performed, a 17F, 70° scope (Storz, Culver city, CA)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="50"/>
            <count group_id="B2" value="50"/>
            <count group_id="B3" value="100"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57.6" spread="13.9"/>
                    <measurement group_id="B2" value="61.9" spread="14.8"/>
                    <measurement group_id="B3" value="59.7" spread="14.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="100"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Caucasian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="47"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="91"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Post Procedural Complications, Including Frequency, Urgency, Infection and Time to Resolution of These Symptoms Between the Two Procedures.</title>
        <description>Post procedural complications, including frequency, urgency, infection and time to resolution of these symptoms between the two procedures. Patients were asked to report frequency or urgency as a &quot;yes&quot; or &quot;no&quot;</description>
        <time_frame>1 week after procedure</time_frame>
        <population>A total of 42 participants and 43 participants were analyzed from each group, respectively. Some participants may have reported multiple symptoms, which is why the numbers below may exceed to total number of participants analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Rigid Cystoscopy</title>
            <description>17F, 70° scope (Storz, Culver city, CA)
Cystoscopy: A 16 F flexible cysto urethroscope (Storz, Culver city, CA) is used for flexible cystoscopy. When rigid cystoscopy is performed, a 17F, 70° scope (Storz, Culver city, CA)</description>
          </group>
          <group group_id="O2">
            <title>Flexible Cystoscopy</title>
            <description>16F flexible cysto urethroscope (Storz, Culver city, CA)
Cystoscopy: A 16 F flexible cysto urethroscope (Storz, Culver city, CA) is used for flexible cystoscopy. When rigid cystoscopy is performed, a 17F, 70° scope (Storz, Culver city, CA)</description>
          </group>
        </group_list>
        <measure>
          <title>Post Procedural Complications, Including Frequency, Urgency, Infection and Time to Resolution of These Symptoms Between the Two Procedures.</title>
          <description>Post procedural complications, including frequency, urgency, infection and time to resolution of these symptoms between the two procedures. Patients were asked to report frequency or urgency as a &quot;yes&quot; or &quot;no&quot;</description>
          <population>A total of 42 participants and 43 participants were analyzed from each group, respectively. Some participants may have reported multiple symptoms, which is why the numbers below may exceed to total number of participants analyzed.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>No new symptoms</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Frequency</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Urgency</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Blood in urine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Burning with urination</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Urinary infection</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Duration of Post-procedure Complications</title>
        <description>Duration of post-procedure complications, surveyed 1 week post procedure</description>
        <time_frame>1 week after procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Rigid Cystoscopy</title>
            <description>17F, 70° scope (Storz, Culver city, CA)
Cystoscopy: A 16 F flexible cysto urethroscope (Storz, Culver city, CA) is used for flexible cystoscopy. When rigid cystoscopy is performed, a 17F, 70° scope (Storz, Culver city, CA)</description>
          </group>
          <group group_id="O2">
            <title>Flexible Cystoscopy</title>
            <description>16F flexible cysto urethroscope (Storz, Culver city, CA)
Cystoscopy: A 16 F flexible cysto urethroscope (Storz, Culver city, CA) is used for flexible cystoscopy. When rigid cystoscopy is performed, a 17F, 70° scope (Storz, Culver city, CA)</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Post-procedure Complications</title>
          <description>Duration of post-procedure complications, surveyed 1 week post procedure</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.7" spread="3.4"/>
                    <measurement group_id="O2" value="4.6" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Visual Analog Pain Scale</title>
        <description>The Visual analog pain scale measures patient-reported pain levels from 0-10, with 0 being no pain reported and 10 being the highest level of pain reported. In this study, researchers compared pain levels between females who had rigid and flexible cystoscopies.</description>
        <time_frame>Immediately after procedure</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Flexible Cystoscopy</title>
            <description>16F flexible cysto urethroscope (Storz, Culver city, CA)
Cystoscopy: A 16 F flexible cysto urethroscope (Storz, Culver city, CA) is used for flexible cystoscopy. When rigid cystoscopy is performed, a 17F, 70° scope (Storz, Culver city, CA)</description>
          </group>
          <group group_id="O2">
            <title>Rigid Cystoscopy</title>
            <description>17F, 70° scope (Storz, Culver city, CA)
Cystoscopy: A 16 F flexible cysto urethroscope (Storz, Culver city, CA) is used for flexible cystoscopy. When rigid cystoscopy is performed, a 17F, 70° scope (Storz, Culver city, CA)</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Analog Pain Scale</title>
          <description>The Visual analog pain scale measures patient-reported pain levels from 0-10, with 0 being no pain reported and 10 being the highest level of pain reported. In this study, researchers compared pain levels between females who had rigid and flexible cystoscopies.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.9" lower_limit="0.1" upper_limit="2.72"/>
                    <measurement group_id="O2" value="0.5" lower_limit="0" upper_limit="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Flexible Cystoscopy</title>
          <description>16F flexible cysto urethroscope (Storz, Culver city, CA)
Cystoscopy: A 16 F flexible cysto urethroscope (Storz, Culver city, CA) is used for flexible cystoscopy. When rigid cystoscopy is performed, a 17F, 70° scope (Storz, Culver city, CA)</description>
        </group>
        <group group_id="E2">
          <title>Rigid Cystoscopy</title>
          <description>17F, 70° scope (Storz, Culver city, CA)
Cystoscopy: A 16 F flexible cysto urethroscope (Storz, Culver city, CA) is used for flexible cystoscopy. When rigid cystoscopy is performed, a 17F, 70° scope (Storz, Culver city, CA)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Lieschen Quiroz, MD</name_or_title>
      <organization>University of Oklahoma Health Sciences Center</organization>
      <phone>405-271-8787</phone>
      <email>lieschen-quiroz@ouhsc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

